Article
Multidisciplinary Sciences
Wang Shu, Wu Tao, Hu Chunyan, Fan Jie, Liu Yuan, Xu Yan, Zhang Huan, Xie Liang
Summary: The study found that Geriatric Nutritional Risk Index (GNRI) is correlated with postoperative recovery and complications in prostate cancer patients, and serves as an effective predictive marker.
Article
Microbiology
I Portillo-Calderon, M. Ortiz-Padilla, B. De Gregorio-Iaria, V Merino-Bohorquez, J. Blazquez, J. Rodriguez-Bano, J. M. Rodriguez-Martinez, A. Pascual, F. Docobo-Perez
Summary: The combination treatment of fosfomycin and amikacin can quickly reduce bacterial burden and prevent the emergence of resistant subpopulations against fosfomycin-heteroresistant strains, while monotherapy with either amikacin or fosfomycin may risk treatment failure.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
(2021)
Article
Infectious Diseases
Alice Le Menestrel, Francois Guerin, Francoise Chau, Laurent Massias, Laura Benchetrit, Vincent Cattoir, Bruno Fantin, Victoire de Lastours
Summary: Combining colistin and fosfomycin shows synergistic and bactericidal effects against NDM-1-producing E. coli, reducing mortality and bacterial loads in vitro and in vivo, while preventing the selection of resistant mutants. However, the combination may not fully prevent the emergence of fosfomycin-resistant mutants in colistin-resistant strains.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2022)
Article
Radiology, Nuclear Medicine & Medical Imaging
Liang Dong, Yun Su, Yinjie Zhu, Mark C. Markowski, Mei Xin, Michael A. Gorin, Baijun Dong, Jiahua Pan, Martin G. Pomper, Jianjun Liu, Kenneth J. Pienta, Wei Xue, Steven P. Rowe
Summary: This study evaluated the association between a new biochemical recurrence risk stratification system and PSMA-targeted PET/CT findings. High-risk BCR patients had a higher positive rate on PSMA PET/CT scans, and they were independent predictors of positive scan results. The combination of BCR risk group and prostate-specific antigen showed a higher area under the curve compared to using prostate-specific antigen alone.
JOURNAL OF NUCLEAR MEDICINE
(2022)
Article
Microbiology
Tzu-Ting Chen, Yun-Fu Chang, Yea-Chwen Wu
Summary: This retrospective study evaluated the use and side effects of fosfomycin in critically ill patients in Taiwan. The study included 42 patients who received fosfomycin treatment from a teaching hospital. The main indication for fosfomycin use was urinary tract infections, with Escherichia coli being the most frequently identified pathogen. The study found that fosfomycin combined with other drugs had a high clinical success rate and may be an effective and safe antibiotic for multidrug-resistant infections in critically ill patients.
Article
Urology & Nephrology
Matthew J. Roberts, Mark D. Chatfield, George Hruby, Rohan Nandurkar, Paul Roach, Jo Anne Watts, Thomas Cusick, Andrew Kneebone, Thomas Eade, Bao Ho, Andrew Nguyen, Colin Tang, Michael McCarthy, Roslyn Francis, Phillip Stricker, Louise Emmett
Summary: In patients with post-RP BCR, PSMA-PET findings and receipt of SRT predict event-free survival (EFS). Among patients receiving SRT, PSMA status combined with EAU risk grouping is the most predictive of EFS.
Article
Dermatology
Wei Zhu, Lingfeng Wu, Wenhua Xie, Gaoyue Zhang, Yanqin Gu, Yansong Hou, Yi He
Summary: A meta-analysis compared the wound infection rates between robotic-assisted radical prostatectomy and retropubic radical prostate surgery. The analysis showed that robotic-assisted surgery had significantly lower rates of surgical site wound infection and infected lymphoceles compared to retropubic surgery. However, caution is needed in interpreting the results due to small sample sizes in some of the included studies.
INTERNATIONAL WOUND JOURNAL
(2023)
Article
Microbiology
Hidetada Hirakawa, Ayako Takita, Yumika Sato, Suguru Hiramoto, Yusuke Hashimoto, Noriyasu Ohshima, Yoji A. Minamishima, Masami Murakami, Haruyoshi Tomita
Summary: The spread of drug-resistant bacteria is a major threat. Fosfomycin has recently gained attention for its effectiveness against drug-resistant bacteria. In this study, the researchers identified two genes, ackA and pta, that contribute to fosfomycin activity against Escherichia coli.
MICROBIOLOGY SPECTRUM
(2023)
Article
Urology & Nephrology
Do Gyeong Lim, Seung Il Jung, Eu Chang Hwang, Tae-Hyoung Kim, Sangrak Bae, Jung-Sik Huh, Seung-Ju Lee, Hong Chung, Hoon Choi
Summary: This study examined the increasing infectious complications caused by fluoroquinolone-resistant organisms in transrectal ultrasound-guided prostate biopsy (TRUSPB) in men and identified risk factors for infective complications. The results showed that combination antibiotic prophylaxis with fluoroquinolone and fosfomycin had a lower rate of infectious complications compared to monotherapy with fosfomycin or fluoroquinolone. Additionally, healthcare utilization was found to be an independent risk factor for infectious complications after TRUSPB.
INVESTIGATIVE AND CLINICAL UROLOGY
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Hannah Lamberg, Prasad R. Shankar, Karandeep Singh, Elaine M. Caoili, Arvin K. George, Caitlin Hackett, Anna Johnson, Matthew S. Davenport
Summary: This study aimed to evaluate the predictive ability and interrater agreement of MRI-based anatomic measurements, specifically the coronal membranous urethra length (MUL), for urinary continence after radical prostatectomy (RP). The study found that longer MUL was associated with improved continence outcomes after RP, while other MRI variables had no predictive ability. Age and baseline urinary function score were the only other predictive clinical variables. Interrater agreement of MRI variables was moderate among readers with specific training and poor among those without training.
Article
Oncology
Jihye Hyun, Moon Soo Ha, Seung Young Oh, Jong Hyun Tae, Byung Hoon Chi, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung, Tuan Thanh Nguyen, Jung Hoon Kim, Jin Wook Kim, Yong Seong Lee, Jooyoung Lee, Se Young Choi
Summary: This study aimed to assess the trends in urinary tract infections (UTIs) and prognosis of patients with prostate cancer after radical prostatectomy (RP) and radiation therapy (RT) as definitive treatment options. The results showed that RP posed a higher risk of UTIs in the early follow-up period, while RT had a higher incidence of UTIs in the chronic phase (>12 months). The robot-assisted RP group had a lower risk of UTIs compared to the open/laparoscopic RP group.
Article
Infectious Diseases
Selene Rebecca Boncompagni, Maria Micieli, Tiziana Di Maggio, Noemi Aiezza, Alberto Antonelli, Tommaso Giani, Gloria Padoani, Silvia Vailati, Lucia Pallecchi, Gian Maria Rossolini
Summary: This study investigated the activity of fosfomycin, colistin, and their combination against multidrug-resistant Gram-negative pathogens. The results showed that the combination of fosfomycin and colistin exhibited synergistic effects against biofilms and reduced the emergence of drug-resistant subpopulations.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2022)
Article
Multidisciplinary Sciences
Jaehun Jung, Gi Hwan Bae, Jae Heon Kim, Jaehong Kim
Summary: This study aimed to evaluate the clinical impact of robot-assisted radical prostatectomy (RARP) on health outcomes in Korean patients with prostate cancer (PCa). The study found that RARP had a higher risk of overall mortality within 3 and 12 months compared to radical prostatectomy (RP). The RARP group in hospitals with the largest PCa surgery volume had higher mortality rates and more surgical complications than the total RARP patients. The study suggests that RARP may not be superior to RP, possibly due to increased robotic surgery in the elderly.
SCIENTIFIC REPORTS
(2023)
Article
Urology & Nephrology
Giorgio Calleris, Giancarlo Marra, Nicole Benfant, Pawel Rajwa, Mohamed Ahmed, Andre Abreu, Giovanni Cacciamani, Alireza Ghoreifi, Luis Ribeiro, Thilo Westhofen, Rafael Tourinho-Barbosa, Yannic Raskin, Hans Veerman, Simone Albisinni, Joseph A. Smith, Morgan Roupret, Marco Oderda, Emilia Massari, Raj Persad, Henk Van Der Poel, Steven Joniau, Rafael Sanchez-Salas, Alexander Kretschmer, Paul Cathcart, Inderbir Gill, R. Jeffrey Karnes, Derya Tilki, Shahrokh F. Shariat, Karim Touijer, Paolo Gontero
Summary: Salvage radical prostatectomy (sRP) is recommended for locally radiorecurrent prostate cancer patients who meet the criteria set by the European Association of Urology (EAU). This retrospective study found that adhering to the EAU criteria was associated with better pathological and functional outcomes, as well as improved metastasis-free survival, prostate-specific antigen-free survival, and overall survival.
EUROPEAN UROLOGY FOCUS
(2023)
Article
Medicine, Research & Experimental
Mohammad Alyamani, Patrick Michael, Daniel Hettel, Lewis Thomas, Scott D. Lundy, Mike Berk, Mona Patel, Jianbo Li, Hooman Rashidi, Jesse K. McKenney, Eric A. Klein, Nima Sharifi
Summary: This study reveals that some men have enriched levels of testosterone (T) in the prostate region, which is associated with higher rates of prostate cancer recurrence. These findings suggest that the role of local androgen delivery in prostate cancer has been underestimated.
JOURNAL OF CLINICAL INVESTIGATION
(2023)
Review
Urology & Nephrology
Sean Ong, Kenneth Chen, Jeremy Grummet, John Yaxley, Matthijs J. Scheltema, Phillip Stricker, Kae Jack Tay, Nathan Lawrentschuk
Summary: This article provides a summary and discussion of international guidelines, position statements, and consensus statements on focal therapy for prostate cancer. The lack of long-term randomized data for focal therapy is highlighted, and the need for high-quality clinical trials with robust outcomes is emphasized. The current consensus and position statements are heterogeneous, indicating a need for globally accepted guidelines for focal therapy planning and follow-up.
Review
Urology & Nephrology
Deshin Reddy, Abdullah Ebrahim Laher, Nathan Lawrentschuk, Ahmed Adam
Summary: This study conducted a systematic review of all cases of spontaneous rupture of the urinary bladder (SRUB), providing a comprehensive analysis of demographic data, associated comorbidities, clinical presentation, diagnosis, relevant laboratory findings, associated factors, management, morbidity and mortality.
Article
Urology & Nephrology
Kenneth Chen, Nathan Lawrentschuk
Editorial Material
Urology & Nephrology
Nathan Lawrentschuk
JOURNAL OF UROLOGY
(2023)
Review
Oncology
Matthew Alberto, Arthur Yim, Nathan Lawrentschuk, Damien Bolton
Summary: Advanced prostate cancer has a higher mortality rate compared to localized prostate cancer, making it crucial to study its development mechanisms and potential pathways for novel treatments. Prostate cancer is the second most common cancer in men, with increasing prevalence due to an aging population. It is important to understand the evolving mechanisms of progression in order to address the significant morbidity and mortality associated with advanced prostate cancer, where treatment options are linked to lipid metabolism.
Article
Urology & Nephrology
Gavin Wei, Weranja Ranasinghe, Melanie Evans, Damien Bolton, Lachlan Dodds, Mark Frydenberg, Paul Kearns, Nathan Lawrentschuk, Declan G. Murphy, Jeremy Millar, Nathan Papa
Summary: This study retrospectively analyzed patients who underwent prostate biopsy between 2011 and 2020 in the Victorian Prostate Cancer Outcomes Registry. The findings showed a significant decrease in the proportion of GG 1 prostate cancer, especially in younger men. The percentage of interventional management for GG 1 disease also decreased substantially. These results reflect the implementation of major changes in diagnostic and treatment guidelines and provide important insights for future treatment allocation.
Article
Surgery
Bradley J. Gardiner, Jessica P. Bailey, Mia A. Percival, Beth A. Morgan, Victoria M. Warner, Sue J. Lee, C. Orla Morrissey, David M. Kaye, Anton Y. Peleg, Andrew J. Taylor
Summary: This study evaluated the incidence and severity of cytomegalovirus (CMV) infection in seropositive heart transplant recipients and found that CMV infection was associated with longer hospitalization, increased intensive care readmission, and higher mortality rates. The use of valganciclovir prophylaxis was protective against CMV infection. These findings support the routine use of antiviral prophylaxis in all CMV seropositive heart transplant recipients.
CLINICAL TRANSPLANTATION
(2023)
Review
Oncology
Daryl Thompson, Nathan Lawrentschuk, Damien Bolton
Summary: Epigenetic changes are common in urological cancers and have potential as targets for cancer therapy. There have been 25 clinical trials investigating targeted epigenetic therapy in bladder cancer, but no phase 3 trials have been conducted so far. Epigenetics is a rapidly advancing field and holds great promise for the treatment of bladder cancer.
Article
Transplantation
Jenny Li, Bradley J. Gardiner, Sanda Stankovic, Clare V. L. Oates, Yvonne Cristiano, Bronwyn J. Levvey, Andrew G. Brooks, Gregory I. Snell, Glen P. Westall, Lucy C. Sullivan
Summary: This study compared the effectiveness of two commercial assays (QFN-CMV and T-Track) in predicting the risk of CMV disease in lung transplant recipients. The results showed that both assays had good predictive ability for CMV replication in the blood, but were unable to predict CMV replication in the lung allograft.
TRANSPLANTATION DIRECT
(2023)
Editorial Material
Urology & Nephrology
Kenneth Chen, Sean Ong, Kandarpa Vasundhara, Chow Kit Mun, Isabella Williams, Ravindran Kanesvaran, John Yuen Shyi Peng, Arun A. Azad, Nathan Lawrentschuk
Article
Urology & Nephrology
David C. Homewood, Jonathan S. O'Brien, Todd Manning, Brian Kelly, Philip Chan, Ben Thomas, Nathan Lawrentschuk
Editorial Material
Urology & Nephrology
Siyu Huang, David C. Chen, Jordan Santucci, Declan G. Murphy, Nathan Lawrentschuk
Editorial Material
Urology & Nephrology
Gideon Ptasznik, Brian D. Kelly, Declan Murphy, Nathan Lawrentschuk, Veeru Kasivisvanathan, Mark Page, Sean Ong, Daniel Moon
Article
Urology & Nephrology
Dominic Bagguley, Laurence Harewood, Dean McKenzie, Gideon Ptasznik, Sean Ong, Thilakavathi Chengodu, Dixon Woon, Kenneth Sim, James Sheldon, Nathan Lawrentschuk
Summary: The primary objective of this study is to determine the additional value of PSMA PET/CT in risk stratification and predicting the likelihood of failure in men with newly diagnosed prostate cancer who would have otherwise been suitable for active surveillance. The secondary objectives include determining the value of PSMA PET/CT in comparison to repeat mpMRI, developing a nomogram to predict failure in men with high-risk features, and conducting follow-up studies on molecular biomarkers and genetic assays.
Article
Urology & Nephrology
Ellen O'Connor, Marcus G. Cumberbatch, Conrad Bishop, Nathan Lawrentschuk
JOURNAL OF CLINICAL UROLOGY
(2023)